Literature DB >> 20731607

Interaction of β-carboline alkaloids with RNA.

Shohreh Nafisi1, Zahra Mokhtari Malekabady, Mohammad Ali Khalilzadeh.   

Abstract

β-Carboline alkaloids are present in medicinal plants such as Peganum harmala L., which have been used as folk medicine in anticancer therapy. Recently, they have drawn attention because of their antitumor activities. Despite considerable interest and investigations on alkaloid-DNA complexes, reports on alkaloid-RNA interaction are very limited. This study is the first attempt to investigate the binding of β-carboline alkaloids (harmine, harmane, harmaline, harmalol, and tryptoline) with yeast RNA. The effect of alkaloid complexation on RNA aggregation and condensation was investigated in aqueous solution at physiological conditions, using constant RNA concentration (6.25 mM) and various alkaloid:polynucleotide (phosphate) ratios of 1:240, 1:160, 1:80, 1:40, 1:20, 1:10, 1:5, 1:2, and 1:1. Fourier transform infrared and UV-visible spectroscopic methods were used to determine the ligand-binding modes, the binding constants, and the stability of alkaloid-RNA complexes in aqueous solution. Spectroscopic evidence showed major binding of alkaloids to RNA with overall binding constants of K(harmine)-RNA = 2.95 × 10⁷ M⁻¹, K(harmane)-RNA = 5.62 × 10⁵ M⁻¹, K(harmaline)-RNA = 7.47 × 10⁵ M⁻¹, K(harmalol)-RNA = 4.32 × 10⁵ M⁻¹, and K(tryptoline)-RNA = 3.21 × 10⁵ M⁻¹. The affinity of alkaloids-RNA binding is in the order of harmine > harmaline > harmane > harmalol > tryptoline. No biopolymer secondary structural changes were observed upon alkaloid interaction and RNA remains in the A-family structure in these complexes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20731607     DOI: 10.1089/dna.2010.1087

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  5 in total

1.  Chemoinformatic analysis of alkaloids isolated from Peganum genus.

Authors:  Omer Bayazeid; Tohfa Nasibova
Journal:  Mol Divers       Date:  2021-10-21       Impact factor: 3.364

2.  Identification of Plant-derived Alkaloids with Therapeutic Potential for Myotonic Dystrophy Type I.

Authors:  Ruben Herrendorff; Maria Teresa Faleschini; Adeline Stiefvater; Beat Erne; Tatiana Wiktorowicz; Frances Kern; Matthias Hamburger; Olivier Potterat; Jochen Kinter; Michael Sinnreich
Journal:  J Biol Chem       Date:  2016-06-13       Impact factor: 5.157

3.  Characterization of drug-induced transcriptional modules: towards drug repositioning and functional understanding.

Authors:  Murat Iskar; Georg Zeller; Peter Blattmann; Monica Campillos; Michael Kuhn; Katarzyna H Kaminska; Heiko Runz; Anne-Claude Gavin; Rainer Pepperkok; Vera van Noort; Peer Bork
Journal:  Mol Syst Biol       Date:  2013       Impact factor: 11.429

Review 4.  Pharmacological and therapeutic effects of Peganum harmala and its main alkaloids.

Authors:  Milad Moloudizargari; Peyman Mikaili; Shahin Aghajanshakeri; Mohammad Hossein Asghari; Jalal Shayegh
Journal:  Pharmacogn Rev       Date:  2013-07

Review 5.  Small Molecules Which Improve Pathogenesis of Myotonic Dystrophy Type 1.

Authors:  Marta López-Morató; John David Brook; Marzena Wojciechowska
Journal:  Front Neurol       Date:  2018-05-18       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.